Nasdaq:US$15.20 (+0.10) | HKEX:HK$24.00 (+0.20) | AIM:£2.20 (-0.02)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF